ORF16 - Bone and Mineral Metabolism: Parathyroid Disease

ORF Chair-Primary(s)

• TK

  Tiffany Kim (she/her/hers)

  University of California, San Francisco
  San Francisco, CA, United States

  Disclosure information not submitted.
• 

  Dolores Shoback, MD

  UCSF/VA Medical Center
  San Francisco, CA, United States

  Disclosure(s): No financial relationships to disclose

Presentations:

• 1:45 PM - 1:50 PM CT

  Defying Expectations: Low Urinary Calcium in Autosomal Dominant Hypocalcemia Type 1
  

  Rapid and Poster Presenter: Emiliya Zareva, MD – ST LUKE'S HOSPITAL & HEALTH NETWORK

  Co-Author: Dana Ibrahim, MD (she/her/hers) – ST LUKES HOSPITAL

  Senior Author/Primary Investigator: Remy Mimms, DO – ST LUKE'S HOSPITAL & HEALTH NETWORK
• 1:50 PM - 1:55 PM CT

  Parathyroid Carcinoma Masquerading as Recurrent Adenoma: The Diagnostic Challenge of Ultra-Long Latency Recurrence
  

  Rapid and Poster Presenter: Amna Bint I Munir, MD – North Alabama Medical Center

  Co-Author: Sapna Kumari, n/a – Wellspan Health York Hospital

  Co-Author: Shifa Akhter, n/a – North Alabama Medical Center

  Co-Author: Lekshmi Ravi, n/a – North Alabama Medical Center

  Co-Author: Haritha Gandicheruvu, n/a – Sinai Hospital / George Washington university

  Co-Author: Bethany Jackson, n/a – The Florence Endocrine Clinic
• 1:55 PM - 2:00 PM CT

  Management of Refractory Hypercalcemia Due to Parathyromatosis
  

  Rapid and Poster Presenter: Christina Gu, MD – STANFORD UNIVERSITY MEDICAL CENTER

  Co-Author: Kaleena X. Zhang, MD (she/her/hers) – STANFORD UNIVERSITY MEDICAL CENTER

  Co-Author: Helene Puzio, DO – STANFORD UNIVERSITY MEDICAL CENTER

  Senior Author/Primary Investigator: Yasaman Motlaghzadeh, MD, MPH (she/her/hers) – STANFORD UNIVERSITY MEDICAL CENTER

  Senior Author/Primary Investigator: Deborah E. Sellmeyer, MD – STANFORD UNIVERSITY MEDICAL CENTER

  Senior Author/Primary Investigator: Susan Seav, MD – STANFORD UNIVERSITY MEDICAL CENTER

  Co-Author: Susan Seav, MD – STANFORD UNIVERSITY MEDICAL CENTER
• 2:15 PM - 2:30 PM CT

  Characterization of SEP-479, a Novel Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism
  

  Oral Abstract Presenter: Jun Zhang, n/a – Septerna

  Co-Author: Marko Groeger, n/a – Septerna

  Co-Author: Sunny Tang, n/a – Septerna

  Co-Author: Xiaohui Du, n/a – Septerna

  Co-Author: Jialu Wang, n/a – Septerna

  Co-Author: Ryan Strachan, n/a – Septerna

  Co-Author: Jasleen K. Sodhi, n/a – Septerna

  Co-Author: Matthew S. Holdren, n/a – Septerna
• 2:30 PM - 2:45 PM CT

  Investigating Sclerostin and Low-Density Lipoprotein Receptor-Related Protein 5 Interactions in Adipose Tissue during Parathyroid Hormone-Mediated Bone Formation
  

  Oral Abstract Presenter: Belen C. Avelar, n/a – University of Maryland School of Medicine

  Co-Author: Zhu Li, n/a – University of Maryland School of Medicine

  Co-Author: Gillian McKayla Choquette, n/a (she/her/hers) – University of Maryland, Baltimore

  Co-Author: Sushrut M. Pathy, n/a – University of Maryland School of Medicine

  Senior Author/Primary Investigator: Ryan C. Riddle, PhD (he/him/his) – University of Maryland School of Medicine
• 2:45 PM - 3:00 PM CT

  Palopegteriparatide Treatment in Adults with Hypoparathyroidism: Final Results of the Phase 3 PaTHway Trial
  

  Oral Abstract Presenter: Aliya A. Khan, MD,FRCP,FACP, FACE (she/her/hers) – McMaster University

  Co-Author: Bart L. Clarke, MD – Mayo Clinic

  Co-Author: Mishaela R. Rubin, MD – Columbia University Irving Medical Center

  Co-Author: Peter Schwarz, MD – Rigshospitalet, University of Copenhagen

  Co-Author: Dolores M. Shoback, MD – UCSF/VA Medical Center

  Co-Author: Claudia Gagnon, MD – Université Laval

  Co-Author: Andrea Palermo, MD (he/him/his) – Fondazione Policlinico Universitario Campus Bio-Medico

  Co-Author: Lisa G. Abbott, MD – Northern Nevada Endocrinology

  Co-Author: Lynn Kohlmeier, MD – Spokane Osteoporosis and Endocrinology

  Co-Author: Elena Tsourdi, MD – Uniklinikum Dresden

  Co-Author: Filomena Cetani, MD, PhD – University of Pisa

  Co-Author: Rajesh K. Jain, MD – University of Chicago

  Co-Author: Mark Warren, MD – Physicians East

  Co-Author: Carol Zhao, MS – Ascendis Pharma, Inc

  Co-Author: Bryant Lai, PharmD – Ascendis Pharma, Inc.

  Co-Author: Michael S. Ominsky, PhD – Ascendis Pharma, Inc.

  Co-Author: Jenny Ukena, MD – Ascendis Pharma, Inc.

  Co-Author: Christopher T. Sibley, MD – Ascendis Pharma, Inc

  Senior Author/Primary Investigator: Aimee D. Shu, MD – Ascendis Pharma, Inc

  Co-Author: Lars Rejnmark, DMSc, PhD – Aarhus University
• 3:00 PM - 3:15 PM CT

  Efficacy and Safety of Once-Weekly Canvuparatide in Patients with Hypoparathyroidism: Results from Avail, a Phase 2 Randomized Clinical Trial
  

  Oral Abstract Presenter: Mishaela R. Rubin, MD – Columbia University Irving Medical Center

  Co-Author: Lisa G. Abbott, MD – Northern Nevada Endocrinology

  Co-Author: Richard D DiMarchi, PhD – Indiana University

  Co-Author: Daniel Katselnik, MD – Consano Clinical Research

  Co-Author: Salomon Azoulay, MD – MBX Biosciences, Inc.

  Co-Author: Andreas G Moraitis, MD – MBX Biosciences, Inc.

  Co-Author: Kristi Schneider, RN, MSN, ANP – MBX Biosciences, Inc.

  Co-Author: Michael Zhao, PhD – MBX Biosciences, Inc.

  Co-Author: María Belén Zanchetta, Dra – Universidad del Salvador